12anticoagulants
Warfrin Monitering
Iverson Genetic Testing Client Presentation
CYP2C9 Haplotype Structure and Association with Clinical Outcomes
Coagulants and anti coagulants
Bio transformation of Warfarin
MedChem Anticoagulants ACE Inhibitors V2
Anticoagulants and Antibiotics
Vascular Pharmacology Phil Copeman and Alex Hammant.
Pharmacogenomics Case study 1: Warfarin. Warfarin overview Warfarin is an anticoagulant drug which inhibits vitamin K 2,3-epoxide reductase. Warfarin.
Thrombosis, Embolism, Infarction. Bleeding and stopping bleeding Extravasation of RBCs into tissues—not just fluids and solutes Enclosed bleeding: petechia,
Oral Anticoagulant Therapy Benedict R. Lucchesi, M.D., Ph.D. Department of Pharmacology University of Michigan Medical School.
